Das Max-Planck-Institut für Kognitions- und Neurowissenschaften ist eine außeruniversitäre Forschungseinrichtung der Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., die sich der Erforschung ...

During the past decade, Max Planck Institute for Human Cognitive and Brain Sciences conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Max Planck Institute for Human Cognitive and Brain Sciences" #1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Leipzig University Medical Center" with 2 trials as a collaborator, "Berlin" with 1 trials as a collaborator, "DFG - Deutsche Forschungs Gemeinschaft (German Research Foundation)" with 1 trials as a collaborator and "Evolva SA" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Max Planck Institute for Human Cognitive and Brain Sciences" are "Gilles de la Tourette Syndrome" (2 trials), "Tourette Syndrome" (2 trials), "Healthy" (1 trials), "Healthy Volunteers" (1 trials) and "Overweight and Obesity" (1 trials). Many other conditions were trialed in "Max Planck Institute for Human Cognitive and Brain Sciences" in a lesser frequency.

Most popular intervention types in "Max Planck Institute for Human Cognitive and Brain Sciences" are "Device" (2 trials), "Dietary Supplement" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Inulin" (1 trials), "Lifestyle intervention" (1 trials), "MRI scanner (7 Tesla)" (1 trials) and "PET/MR scanner" (1 trials). Other intervention names were less common.

The vast majority of trials in "Max Planck Institute for Human Cognitive and Brain Sciences" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Max Planck Institute for Human Cognitive and Brain Sciences". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Max Planck Institute for Human Cognitive and Brain Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Max Planck Institute for Human Cognitive and Brain Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".